Developer docs
API playgroundTry for free, no card

Search company profiles

Bonnie J. Addario Lung Cancer Foundation

Full company profile

uuid000pkgd

Namestring
Bonnie J. Addario Lung Cancer Foundation
Legal namestring
Bonnie J. Addario Lung Cancer Foundation
Company typeenum
Private
Founded yearint
2006
Descriptiontext

GO2 for Lung Cancer, formerly the Bonnie J. Addario Lung Cancer Foundation, is a U.S.-based nonprofit founded in 2006 and headquartered in San Carlos, California. The organization is dedicated to eradicating lung cancer through an integrated model spanning direct patient support, research advancement, and policy advocacy. Its service portfolio includes a staffed HelpLine (1-800-298-2436), peer-to-peer programs (Phone Buddy, Gathering HOPE, Mind Over Matter), virtual and in-person educational events (Lung Cancer Living Room), clinical trial navigation, biomarker testing education, and a Centers of Excellence network spanning more than 600 screening and care sites across the United States. It also operates research programs covering immunotherapy, precision medicine, and small cell lung cancer, and runs a national advocacy program engaging Capitol Hill and the Lung Cancer Voices Summit.

The organization serves four primary constituencies: lung cancer patients and survivors, caregivers and family members, at-risk individuals seeking screening guidance, and healthcare professionals (through a dedicated HCP portal). All patient-facing services and educational materials are provided free of charge; the organization does not sell products or license technology. Revenue is generated entirely through charitable contributions, including one-time and recurring donations from individuals, corporations, and foundations, with no publicly disclosed financial figures.

The organization is currently led by a founder legacy (Bonnie Addario) and is conducting a formal CEO search in partnership with Vetted Solutions. It has cumulatively secured $245M in federal lung cancer research funding, recorded 125K+ uses of its free support services across 43 states and 148 countries, enrolled 1,165 participants in research studies in the past year, and reached an estimated 43M people through public service awareness campaigns. Operating headcount is in the 11-50 range, and there is no disclosed technology platform, app, or AI/ML capability underlying its service delivery.

Short descriptiontext

GO2 for Lung Cancer is a U.S. nonprofit, founded 2006, that provides free patient support, education, and research programs for people affected by lung cancer through a 600+ site Centers of Excellence network, staffed HelpLine, peer-support groups, and federal research funding advocacy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Carlos, United States
HQ citystring
San Carlos
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
lung cancer support, cancer patient services, cancer research funding, nonprofit health advocacy, cancer education resources
Industry2 codes
1Lung Cancer Screening & Pulmonary Nodule Clinic
CodeHLAKANAIPrimaryYes
2Oncology Pathways & Precision Medicine Decision Support
CodeHLACAGAHPrimaryNo
NAICS code1 code
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Health Services8000
Product category
Nonprofit Cancer Support Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Fundraising
TypeSubscription Recurring
Description

The organization relies on charitable donations from individuals, corporations, and foundations to fund its patient support services, research programs, and advocacy initiatives. Donation options include one-time and monthly recurring giving.

go2.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

GO2 for Lung Cancer (formerly the Bonnie J. Addario Lung Cancer Foundation) is a nonprofit patient-driven philanthropy that provides free lung cancer support services, education, and research funding. It operates a network of 600+ Centers of Excellence for screening and care, offers peer support programs (Phone Buddy, Gathering HOPE), one-on-one assistance via a HelpLine, and funds research aimed at eradicating lung cancer.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 125K+ uses of free support services across 43 states and 148 countries
+4 more records
Product overview1 text field

GO2 for Lung Cancer offers a comprehensive suite of patient support, education, and research services for individuals affected by lung cancer. The organization's offerings include direct support services (HelpLine, Phone Buddy, Gathering HOPE, Mind Over Matter, and Lung Cancer Living Room®), educational resources (Educational Materials and Video Library), a network of 600+ Centers of Excellence for screening and care, clinical trial navigation, research programs, advocacy initiatives, and community events. These services work together to provide holistic support from early detection through treatment and survivorship.

Product and service1 record
1HelpLine
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

LUNGevity is the largest lung cancer-focused nonprofit in the U.S., funding research, providing patient education, and running community programs. It is the most direct peer to GO2 in mission, target population, and program mix.

TypeBroad incumbent
Description

The American Lung Association is a large, established lung health nonprofit with broader scope (asthma, COPD, tobacco control) that also funds lung cancer research and runs patient support. It competes for the same donor dollars and awareness attention as GO2.

TypeBroad incumbent
Description

Komen is the dominant single-disease cancer nonprofit (breast cancer) and operates the same model of research funding, patient navigation, advocacy, and walk/run fundraising at much greater scale. It is the gold-standard operational template GO2 is built against.

TypeBroad incumbent
Description

ACS is the broadest U.S. cancer nonprofit, funding research, running a 24/7 helpline, and providing patient navigation across all cancer types including lung. It is a peer in service model and donor base, though not lung-cancer-specific.

TypeDirect peer
Description

CRI funds immunotherapy and cancer immunology research across tumor types, including lung cancer. It is comparable in research-funding mission and academic partnership model, and overlaps on precision-medicine advocacy.

TypeDirect peer
Description

SU2C funds translational cancer research through high-profile media-driven fundraising campaigns and "dream team" grants covering multiple cancer types including lung. It competes for the same major-donor and corporate-partner dollars.

TypeDirect peer
Description

Prevent Cancer Foundation funds cancer prevention and early-detection research, runs public awareness campaigns, and advocates for screening policy—directly overlapping GO2's screening and early-detection mission.

TypeBroad incumbent
Description

Livestrong is a cancer survivor support and navigation nonprofit that provides patient services and advocacy across cancer types. It is comparable in patient-navigation, fundraising model, and advocacy positioning, though not disease-specific.

TypeOthers
Description

NCI is the federal government's principal agency for cancer research and the largest single source of U.S. cancer research funding. GO2's advocacy explicitly targets NCI appropriations, making it the most consequential adjacent player in GO2's ecosystem.

TypeDirect peer
Description

Cancer Support Community provides free psychosocial support, navigation, and education to cancer patients and caregivers across tumor types. It overlaps directly with GO2's peer-support, education, and community-program model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bonnie J. Addario Lung Cancer Foundation

Nonprofit Cancer Support Serviceslungcancerfoundation.org

GO2 for Lung Cancer is a U.S. nonprofit, founded 2006, that provides free patient support, education, and research programs for people affected by lung cancer through a 600+ site Centers of Excellence network, staffed HelpLine, peer-support groups, and federal research funding advocacy.

What Bonnie J. Addario Lung Cancer Foundation does

GO2 for Lung Cancer, formerly the Bonnie J. Addario Lung Cancer Foundation, is a U.S.-based nonprofit founded in 2006 and headquartered in San Carlos, California. The organization is dedicated to eradicating lung cancer through an integrated model spanning direct patient support, research advancement, and policy advocacy. Its service portfolio includes a staffed HelpLine (1-800-298-2436), peer-to-peer programs (Phone Buddy, Gathering HOPE, Mind Over Matter), virtual and in-person educational events (Lung Cancer Living Room), clinical trial navigation, biomarker testing education, and a Centers of Excellence network spanning more than 600 screening and care sites across the United States. It also operates research programs covering immunotherapy, precision medicine, and small cell lung cancer, and runs a national advocacy program engaging Capitol Hill and the Lung Cancer Voices Summit.

The organization serves four primary constituencies: lung cancer patients and survivors, caregivers and family members, at-risk individuals seeking screening guidance, and healthcare professionals (through a dedicated HCP portal). All patient-facing services and educational materials are provided free of charge; the organization does not sell products or license technology. Revenue is generated entirely through charitable contributions, including one-time and recurring donations from individuals, corporations, and foundations, with no publicly disclosed financial figures.

The organization is currently led by a founder legacy (Bonnie Addario) and is conducting a formal CEO search in partnership with Vetted Solutions. It has cumulatively secured $245M in federal lung cancer research funding, recorded 125K+ uses of its free support services across 43 states and 148 countries, enrolled 1,165 participants in research studies in the past year, and reached an estimated 43M people through public service awareness campaigns. Operating headcount is in the 11-50 range, and there is no disclosed technology platform, app, or AI/ML capability underlying its service delivery.

Bonnie J. Addario Lung Cancer Foundation firmographics

Firmographics
Name
Bonnie J. Addario Lung Cancer Foundation
Legal name
Bonnie J. Addario Lung Cancer Foundation
Website
https://lungcancerfoundation.org
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
GO2 for Lung Cancer is a U.S. nonprofit, founded 2006, that provides free patient support, education, and research programs for people affected by lung cancer through a 600+ site Centers of Excellence network, staffed HelpLine, peer-support groups, and federal research funding advocacy.
Ownership category
akta.pro rank

Bonnie J. Addario Lung Cancer Foundation industry classification

Industry
Product category
Nonprofit Cancer Support Services
NAICS
Voluntary Health Organizations (813212)
SIC
Services-Health Services (8000)
akta.pro primary industry
Lung Cancer Screening & Pulmonary Nodule Clinic (HLAKANAI)
akta.pro secondary industry
Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)

Keywords

  • Lung cancer support
  • Cancer patient services
  • Cancer research funding
  • Nonprofit health advocacy
  • Cancer education resources

Where Bonnie J. Addario Lung Cancer Foundation is headquartered

Location

Headquarters

HQ city
San Carlos
HQ country
United States
HQ region
North America

Markets served

Bonnie J. Addario Lung Cancer Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Fundraising: The organization relies on charitable donations from individuals, corporations, and foundations to fund its patient support services, research programs, and advocacy initiatives. Donation options include one-time and monthly recurring giving.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Bonnie J. Addario Lung Cancer Foundation product offering

Product offering

Core offering

GO2 for Lung Cancer (formerly the Bonnie J. Addario Lung Cancer Foundation) is a nonprofit patient-driven philanthropy that provides free lung cancer support services, education, and research funding. It operates a network of 600+ Centers of Excellence for screening and care, offers peer support programs (Phone Buddy, Gathering HOPE), one-on-one assistance via a HelpLine, and funds research aimed at eradicating lung cancer.

Product overview

GO2 for Lung Cancer offers a comprehensive suite of patient support, education, and research services for individuals affected by lung cancer. The organization's offerings include direct support services (HelpLine, Phone Buddy, Gathering HOPE, Mind Over Matter, and Lung Cancer Living Room®), educational resources (Educational Materials and Video Library), a network of 600+ Centers of Excellence for screening and care, clinical trial navigation, research programs, advocacy initiatives, and community events. These services work together to provide holistic support from early detection through treatment and survivorship.

Differentiator

Problem solved

Functional benefit

Products and services

  • HelpLine

Quantifiable outcome

  • 125K+ uses of free support services across 43 states and 148 countries
  • +4 more outcomes

Companies that use Bonnie J. Addario Lung Cancer Foundation

Customer profile

Segments4 records

Ideal customer profiles3 records

Bonnie J. Addario Lung Cancer Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bonnie J. Addario Lung Cancer Foundation partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves1 record

Expansion highlights5 records

Bonnie J. Addario Lung Cancer Foundation competitors and assessment

Company assessment

Direct peers

  • LUNGevity Foundation: LUNGevity is the largest lung cancer-focused nonprofit in the U.S., funding research, providing patient education, and running community programs. It is the most direct peer to GO2 in mission, target population, and program mix.
  • Cancer Research Institute: CRI funds immunotherapy and cancer immunology research across tumor types, including lung cancer. It is comparable in research-funding mission and academic partnership model, and overlaps on precision-medicine advocacy.
  • Stand Up To Cancer: SU2C funds translational cancer research through high-profile media-driven fundraising campaigns and "dream team" grants covering multiple cancer types including lung. It competes for the same major-donor and corporate-partner dollars.
  • Prevent Cancer Foundation: Prevent Cancer Foundation funds cancer prevention and early-detection research, runs public awareness campaigns, and advocates for screening policy—directly overlapping GO2's screening and early-detection mission.
  • Cancer Support Community: Cancer Support Community provides free psychosocial support, navigation, and education to cancer patients and caregivers across tumor types. It overlaps directly with GO2's peer-support, education, and community-program model.

Broad incumbents

  • American Lung Association: The American Lung Association is a large, established lung health nonprofit with broader scope (asthma, COPD, tobacco control) that also funds lung cancer research and runs patient support. It competes for the same donor dollars and awareness attention as GO2.
  • Susan G. Komen: Komen is the dominant single-disease cancer nonprofit (breast cancer) and operates the same model of research funding, patient navigation, advocacy, and walk/run fundraising at much greater scale. It is the gold-standard operational template GO2 is built against.
  • American Cancer Society: ACS is the broadest U.S. cancer nonprofit, funding research, running a 24/7 helpline, and providing patient navigation across all cancer types including lung. It is a peer in service model and donor base, though not lung-cancer-specific.
  • Livestrong Foundation: Livestrong is a cancer survivor support and navigation nonprofit that provides patient services and advocacy across cancer types. It is comparable in patient-navigation, fundraising model, and advocacy positioning, though not disease-specific.

Others

  • National Cancer Institute: NCI is the federal government's principal agency for cancer research and the largest single source of U.S. cancer research funding. GO2's advocacy explicitly targets NCI appropriations, making it the most consequential adjacent player in GO2's ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Bonnie J. Addario Lung Cancer Foundation social profiles

Digital presence

Bonnie J. Addario Lung Cancer Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bonnie J. Addario Lung Cancer Foundation leadership team

Management profile

Number of profiles

Profiles1 record

Bonnie J. Addario Lung Cancer Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bonnie J. Addario Lung Cancer Foundation M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bonnie J. Addario Lung Cancer Foundation

What does Bonnie J. Addario Lung Cancer Foundation do?

GO2 for Lung Cancer (formerly the Bonnie J. Addario Lung Cancer Foundation) is a nonprofit patient-driven philanthropy that provides free lung cancer support services, education, and research funding. It operates a network of 600+ Centers of Excellence for screening and care, offers peer support programs (Phone Buddy, Gathering HOPE), one-on-one assistance via a HelpLine, and funds research aimed at eradicating lung cancer.

Is Bonnie J. Addario Lung Cancer Foundation a public or private company?

Bonnie J. Addario Lung Cancer Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Bonnie J. Addario Lung Cancer Foundation founded?

Bonnie J. Addario Lung Cancer Foundation was founded in 2006. It employs 11 to 50 people.

Where is Bonnie J. Addario Lung Cancer Foundation based?

Bonnie J. Addario Lung Cancer Foundation is headquartered in San Carlos, United States, in the North America region.

How does Bonnie J. Addario Lung Cancer Foundation make money?

One revenue line is on record: donations and Fundraising.

Who are Bonnie J. Addario Lung Cancer Foundation's main competitors?

Direct peers on record are LUNGevity Foundation, Cancer Research Institute, Stand Up To Cancer, Prevent Cancer Foundation and Cancer Support Community. Broad incumbents are American Lung Association, Susan G. Komen, American Cancer Society and Livestrong Foundation. National Cancer Institute is listed as an others.

Does Bonnie J. Addario Lung Cancer Foundation have an API?

No public API is recorded for Bonnie J. Addario Lung Cancer Foundation.

What industry is Bonnie J. Addario Lung Cancer Foundation in?

Bonnie J. Addario Lung Cancer Foundation's product category is Nonprofit Cancer Support Services. Its primary akta.pro industry code is HLAKANAI, Lung Cancer Screening & Pulmonary Nodule Clinic, with a secondary code of HLACAGAH, Oncology Pathways & Precision Medicine Decision Support. Its NAICS code is 813212 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBonnie J. Addario Lung Cancer Foundation's Simply the Best Dinner and Gala Honors Those Working on the Front Lines to Fight Lung CancerThe Bonnie J. Addario Lung Cancer Foundation held its annual Simply the Best Dinner and Gala in San Francisco on November 9, 2018, recognizing outstanding contributors in lung cancer research, treatment, and caregiving. Dr. James Mulshine of Rush University received the Asclepios Award for research leadership, while Dr. Scott Antonia of the H. Lee Moffitt Cancer Center received the A Breath Away from the Cure Award for oncology excellence. The event, the foundation's largest annual fundraiser with Takeda Pharmaceuticals as presenting sponsor, raised proceeds for patient services and clinical research projects.PR NewswireBonnie J. Addario Lung Cancer Foundation and ALK-Positive Patient Group Partner to Encourage Members to Join Lung Cancer RegistryThe Bonnie J. Addario Lung Cancer Foundation (ALCF) has partnered with ALK Positive, an online community of over 1,200 members worldwide, to encourage lung cancer patients to join the Lung Cancer Registry. The registry, developed by ALCF along with partners including the American Lung Association and IASLC, provides researchers and clinicians with patient data to advance research for all types of lung cancer, including the rare ALK-positive variant. The partnership aims to accelerate ALK-positive lung cancer research by increasing patient participation and linking patients' data directly to doctors and researchers searching for better treatments.PR NewswireThe Bonnie J. Addario Lung Cancer Foundation Joins Forces with Patient Advocate Group to Advance Care for People with EGFR-Positive Lung CancerThe Bonnie J. Addario Lung Cancer Foundation (ALCF) and the EGFR Resisters, a global patient-driven advocacy group, announced a partnership in August 2018 to raise funds and increase awareness for research benefiting people with EGFR-positive lung cancer. The collaboration combines ALCF's research infrastructure and its arm ALCMI with the EGFR Resisters' network of several hundred patient advocates across 24 countries, aiming to accelerate research into overcoming therapy resistance. EGFR mutations affect up to 15% of non-small cell lung cancer patients in the United States and 35% in Asia.PR NewswireThe Addario Lung Cancer Foundation Honors Oncologist for Groundbreaking Targeted Therapy ResearchThe Bonnie J. Addario Lung Cancer Foundation (ALCF) named Dr. Vassiliki A. Papadimitrakopoulou as the 2018 Addario Lectureship Award recipient for her groundbreaking clinical research in immunotherapy and targeted lung cancer treatments. Dr. Papadimitrakopoulou, chief of Thoracic Medical Oncology at the University of Texas MD Anderson Cancer Center, is being recognized for her leadership in the Lung-MAP clinical trial, which has led to new treatment options helping patients with squamous cell lung cancer live longer. The award was presented at the 19th International Lung Cancer Congress in Huntington Beach, California.PR NewswireThe Bonnie J. Addario Lung Cancer Foundation (ALCF) Earns 4-Star Rating from Charity NavigatorThe Bonnie J. Addario Lung Cancer Foundation received a fourth consecutive 4-star rating from Charity Navigator for its financial health and transparency. The foundation, which raised over $30 million for lung cancer research, is the only lung cancer foundation to earn this rating. The rating aims to build donor confidence in its efforts to turn lung cancer into a chronically managed disease.PR NewswireBonnie J. Addario Lung Cancer Foundation and Van Auken Private Foundation Announce the 2018 Young Innovators Team Award for Lung Cancer ResearchThe Bonnie J. Addario Lung Cancer Foundation, in partnership with the Van Auken Private Foundation, announced the 2018 Young Innovators Team Award to fund teams of young investigators conducting innovative lung cancer research. The award provides up to $250,000 over two to three years to teams within five years of their first faculty appointment, with submissions evaluated on criteria including out-of-the-box research, collaboration, translational potential, and multi-disciplinary approaches. Applications will be accepted from May 31 to July 15, 2018, with award announcements on October 31, 2018.PR NewswireBonnie J. Addario Lung Cancer Foundation Announces Grant Opportunity for Shared Patient and Physician Decision Making in Treatment of Lung CancerThe Bonnie J. Addario Lung Cancer Foundation (ALCF) has announced a Call for Grant Notification to develop initiatives promoting shared decision making as a standard of care in lung cancer treatment across the United States. The grant opportunity is financially supported by Genentech, a member of the Roche Group. This initiative aims to improve patient engagement and physician collaboration through education and training.PR NewswireThe Bonnie J. Addario Lung Cancer Foundation Awards $100,000 to Winners of the Lung Cancer Early Detection Challenge: Concept to ClinicThe Bonnie J. Addario Lung Cancer Foundation announced the winners of its Lung Cancer Early Detection Challenge: Concept to Clinic, distributing a total of $100,000 in prizes to three top contributors who built open-source AI software to help radiologists detect lung cancer earlier from CT scans. The challenge, run by DrivenData in partnership with ALCF, attracted over 600 contributors worldwide and was specifically designed to make artificial intelligence approaches usable by clinicians rather than just for data scientists. Top prizewinners included Willi Gierke ($30,840), Anton Dobrenkii ($26,530), and Serhiy Shekhovtsov ($15,989), with in-kind support from Amazon Web Services, Docker, Fossa GitHub and Travis CI.PR NewswireLung Cancer Patients to Help Medical Community Understand the Side Effects of Immunotherapy TreatmentThe Bonnie J. Addario Lung Cancer Foundation, the American Lung Association, the International Association for the Study of Lung Cancer, and the Society for Immunotherapy of Cancer have launched a collaborative study to gather patient-reported data on side effects from immunotherapy treatments for non-small cell lung cancer. The initiative aims to help doctors better understand toxicity impacts and improve patient care by utilizing information directly from patients and caregivers.PR NewswireThe Bonnie J. Addario Lung Cancer Foundation, the American Lung Association and the International Association for the Study of Lung Cancer Collaborate to Find a Cure for the World's Deadliest CancerThe Bonnie J. Addario Lung Cancer Foundation (ALCF), the American Lung Association's LUNG FORCE, and the International Association for the Study of Lung Cancer (IASLC) announced a collaboration, with IASLC joining as a new member of the Lung Cancer Patient Registry. The Registry is a patient-driven platform where lung cancer patients anonymously share their treatment experiences and outcomes, enabling researchers to query de-identified data and conduct real-world studies. This month, the Registry will launch a study on immunotherapy side effects affecting non-small cell lung cancer patients, aiming to educate patients and families about treatment-related quality-of-life impacts.